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ABSTRACT (BAHASA MALAYSIA) 
Latar belakang: Maklumat perubatan tentang kesan kencing manis ketika mengandung 
terhadap bayi adalah tidak mencukupi walaupun kejadiannya tinggi di Malaysia. Kajian ini 
bertujuan untuk mengenalpasti semua masalah kesihatan dan kecacatan fizikal yang dihadapi 
oleh bayi-bayi ini dan menganalisa faktor risiko yang menjurus kepada penyakit ini. 
Kaedah: Kajian ini dilakukan secara keratan rentas selama empat bulan. Maklumat kesihatan 
ketika mengandung, pemeriksaan fizikal dan masalah kesihatan dikumpulkan daripada 292 
bayi-bayi yang dilahirkan oleh ibu berpenyakit kencing manis. Seterusnya, analisa statistik 
menggunakan T test tidak bersandaran dan regresi logistic dijalankan terhadap pelbagai faktor 
risiko yang menjurus kepada masalah kesihatan atau kecacatan fizikal bayi. 
Keputusan: 94 (32%) bayi mempunyai masalah kesihatan akibat kencing manis ketika 
mengandung. 26 (9%) mengalami masalah yang serius. Purata HbA1c pada trimester ketiga 
ialah 5.9%. Beza purata HbA1c trimester ketiga bagi bayi yang mempunyai masalah kesihatan 
(6.45 ± 1.36%) dengan bayi yang tidak mempunyai masalah (5.53 ± 0.97%) adalah ketara (p = 
0.003). Setiap kenaikan HbA1c sebanyak 1% akan meningkatkan kecenderungan untuk 
mendapat masalah kesihatan sebanyak 2.2 kali ganda. HbA1c <6.5% tidak mempengaruhi 
kecenderungan untuk mendapat masalah kesihatan. 10 (3%) bayi mempunyai masalah fizikal 
yang major. 27 (9%) mempunyai masalah fizikal yang minor. Tiada bacaan signifikan antara 
bacaan HbA1c sebelum mengandung dengan bayi berkecacatan fizikal. 
Kesimpulan: Walaupun kawalan gula ketika mengandung adalah memadai, masalah kesihatan 
bayi-bayi ini masih tinggi. Ini menunjukkan bahawa kawalan kencing manis ketika 
mengandung masih boleh diperhaluskan. Tapisan universal, penekanan pada pendidikan ibu 
mengandung, kawalan gula yang lebih ketat (HbA1c <6.3) akan menjamin kelahiran yang lebih 
selamat. Kajian lanjutan diperlukan untuk mengubah amalan sakit puan sekarang. 
Kata kunci: kecacatan fizikal, kencing manis ketika mengandung, masalah bayi ketika lahir 
 
 
ABSTRACT (ENGLISH) 
Background: National data regarding the neonatal outcome of infants of diabetic mothers is 
lacking despite Malaysia having one of the highest incidences of diabetic pregnancies in the 
region. This study aimed to describe the various neonatal morbidities and birth defects in 
infants of diabetic mothers and analyse their risk factors.  
Methods: In this cross-sectional, descriptive study spanning four months, antenatal history, 
neonatal morbidities and birth defects were assessed in the neonates of 292 diabetic mothers. 
Independent t-test and binary logistic regression were performed to determine the association 
of various risk factors with neonatal morbidities and with birth defects. 
 Results: 94 (32%) infants had neonatal morbidities. 26 (9%) of them had severe morbidities. 
Mean third trimester HbA1c was 5.9%. Infants with neonatal morbidity had statistically higher 
mean third trimester HbA1c level (6.45 ± 1.36%) compared to infants without neonatal 
morbidity (5.53 ± 0.97%), p = 0.003. Every 1% increase in HbA1c increases the odds of having 
neonatal morbidity by 2.2 times (p <0.001). Third trimester HbA1c <6.5% will not affect the 
odds of having neonatal morbidities. 10 (3%) infants had major birth defects (including neural 
tube defects, congenital heart disease, various syndromes, perineal malformation). 27 (9%) had 
minor birth defects. There was no significance between pregestational HbA1c and birth defects. 
Conclusions: Despite good antenatal glycaemic control, current antenatal practices for GDM 
is suboptimal as evidenced by the high incidence of neonatal morbidity. Universal screening, 
emphasis on maternal education, accessible assessment tools and stricter glycaemic control 
(HbA1c <6.3) will lead to a better pregnancy outcome. Further studies documenting similar 
neonatal outcomes will make a stronger case for a review of the national guidelines. 
Keywords: birth defect, gestational diabetes mellitus, neonatal morbidity, Malaysian neonate 
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Introduction: National data regarding the neonatal outcome of infants of diabetic 
mothers is lacking despite Malaysia having one of the highest incidences of diabetic 
pregnancies in the region.  
 
Objectives: This study aimed to describe the various neonatal morbidities and birth 
defects in infants of diabetic mothers and analyse their risk factors.  
 
Patients and Methods: In this cross-sectional, descriptive study spanning four months, 
antenatal history, neonatal morbidities and birth defects were assessed in the neonates of 292 
diabetic mothers. Independent t-test and binary logistic regression were performed to determine 
the association of various risk factors with neonatal morbidities and with birth defects. 
 
  
 Results: 94 (32%) infants had neonatal morbidities. 26 (9%) of them had severe 
morbidities. Mean third trimester HbA1c was 5.9%. Infants with neonatal morbidity had 
statistically higher mean third trimester HbA1c level (6.45 ± 1.36%) compared to infants 
without neonatal morbidity (5.53 ± 0.97%), p = 0.003. Every 1% increase in HbA1c increases 
the odds of having neonatal morbidity by 2.2 times (p <0.001). Third trimester HbA1c <6.5% 
will not affect the odds of having neonatal morbidities. 10 (3%) infants had major birth defects 
(including neural tube defects, congenital heart disease, various syndromes, perineal 
malformation). 27 (9%) had minor birth defects. There was no significance between 
pregestational HbA1c and birth defects. 
 
 Conclusion: Despite good antenatal glycaemic control, current antenatal practices for 
GDM is suboptimal as evidenced by the high incidence of neonatal morbidity. Universal 
screening, emphasis on maternal education, accessible assessment tools and stricter glycaemic 
control (HbA1c <6.3) will lead to a better pregnancy outcome. Further studies documenting 
similar neonatal outcomes will make a stronger case for a review of the national guidelines. 
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ORIGINAL ARTICLE: 
A CROSS-SECTIONAL STUDY ON NEONATAL MORBIDITY AND BIRTH 
DEFECTS IN DIABETIC PREGNANCIES IN MALAYSIA: A SINGLE HOSPITAL 
STUDY 
 
Keywords: birth defect, gestational diabetes mellitus, neonatal morbidity, Malaysian neonate 
 
1.0 INTRODUCTION 
1.1 Overview of Maternal Diabetes 
A diabetic pregnancy is categorized into pregestational diabetes mellitus (PGDM) 
either type 1 or type 2 diabetes mellitus; and gestational diabetes mellitus (GDM). Malaysia 
has one of the highest incidences of diabetic pregnancies at 9.9%1 compared to the median 
incidence in Southeast Asia at 5.4% and European countries at 1.2-3.1%.2 
In 2010, 12,857 babies, delivered in 14 state hospitals in Malaysia, were infants of 
diabetic mothers (IDMs) and this accounted for 9.4% of all pregnancies.3 Labour room 
records at Hospital Universiti Sains Malaysia (HUSM) showed there were 7,000-8,000 
deliveries per year with the incidence of GDM and PGDM in HUSM being similar to the 
national data (8-10%). 
 
1.2 Neonatal Morbidities of Infants of Diabetic Mothers 
An infant of diabetic mother is commonly admitted for various neonatal indications 
and despite this, few studies had been undertaken to evaluate the impact of the disease in 
Malaysia for the past 28 years.1,3,4,5  
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The only national literature on neonatal effects of a diabetic pregnancy was a 
prospective descriptive study over one year at Maternity Hospital Kuala Lumpur in 1989.1 54 
babies out of 24856 live births were IDMs (0.2%). 37% were macrosomic and 13% had 
shoulder dystocia. 50% had at least one neonatal morbidity and 7.4% had major birth defects 
(with one death due to multiple congenital abnormalities). Glucose control in these mothers 
was not documented. 
There was also no prior study to document minor birth defects in IDMs in Malaysia. 
 
1.3 Pathogenesis of Morbidities in Infants of Diabetic Mothers 
 The association between glycaemic control and neonatal morbidity has been shown 
previously6-7 Like a dose-response curve, high pregestational HbA1c level increases the risk 
of hyperglycaemic teratogenicity in a zygote; whereas high third trimester HbA1c level 
exposes a foetus to hyperinsulinism as a response to a hyperglycaemic environment.8 A 
hyperglycaemic state causes increased oxidative stress and epigenetic alterations,9 leading to 
metabolic complications e.g. macrosomia, erythrocytosis and hypoglycaemia; and major birth 
defects.9,10 
 The typical major birth defects associated with diabetic pregnancies (diabetic 
embryopathy) are several subgroups of congenital heart diseases; several subgroups of neural 
tube defects; caudal regression or sacral agenesis; anotia; omphalocoele; small left colon 
syndrome; and genitourinary abnormalities.6,11-13 Certain conditions are more common with 
PGDM than GDM i.e. orofacial cleft, cardiovascular defect, oesophageal or intestinal atresia, 
hypospadias, limb or spinal defect, and polydactyly.6 Chromosomal anomalies were less 
likely to be associated to diabetic pregnancies.13 
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1.4 Evaluation of Glycaemic Control During Pregnancy 
 In Malaysia, the antenatal glucose control of diabetic mothers follow the latest 
national clinical practice guidelines (CPG).14 Monitoring is best done via self-monitoring of 
blood glucose (SMBG) as it closely reflects the actual day-to-day blood glucose levels. In-
hospital or clinic blood sugar profile (BSP) is the alternative way. Both monitoring ways may 
not reflect the true glucose levels as patients are aware of and take good control of their diet 
on the day of the test. This may explain how diabetic mothers with good BSP have high 
HbA1c levels. 
 On the other hand, HbA1c measurement in pregnant mothers is also not accurate as 
they can be falsely lower due to a faster erythrocyte turnover and decreased haemoglobin 
half-life compared to non-pregnant women.15 However, they cannot be manipulated by 
fasting or sudden dietary change as they reflect maternal glycaemic control over three 
months. The most accurate measurement is fructosamine level16 but it is not done due to 
resource constraints. 
 We currently take a cut-off HbA1c level of 6.5% to indicate good maternal glycaemic 
control.14 HbA1c more than 5.6-6.5% in late pregnancy predicts macrosomia and neonatal 
hypoglycaemia.7,17 
   
1.5 Research Objectives 
Published national data about neonatal morbidities and birth defects of IDMs is 
lacking. There is a need to evaluate the disease burden of maternal diabetes on neonates 
owing to the high incidence of maternal diabetes in Malaysia. Hence, the reason for 
undertaking this project. 
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In this study, the primary objective was to describe the incidence of neonatal 
morbidities and birth defects of IDMs born at HUSM. Secondarily, we wanted to determine 
the association between HbA1c level with neonatal morbidities and with birth defects.  
We also wanted to determine the association between other factors (biological and 
sociodemographic) with neonatal morbidities and with birth defects. Results of this study 
would ultimately be among the foundation to improve periconceptional, antenatal, 
intrapartum and postnatal care. 
 
2.0 METHODS 
2.1 Study Design and Setting 
This was a cross-sectional, descriptive study conducted at Hospital Universiti Sains 
Malaysia (HUSM), spanning four months from June to September 2017. HUSM is a teaching 
hospital for medical undergraduate and postgraduate students in the East Coast of Peninsular 
Malaysia. This study was approved by the Research Ethics Committee of the Medical School 
of USM (USM/JEPEM/16120589).  
 
2.2 Sample Size and Subjects 
The sample size calculation for mean difference (power 80%, 95% confidence 
interval) was done using OpenEPI free online open-source calculator.18 The sample size 
needed was 291, obtained by referencing a Danish study in 2011 on macrosomia and late-
pregnancy HbA1c (Group 1 mean 5.6 (SD 0.6); group 2 mean 5.3 (SD 0.5); ratio 7.3).7  
All mothers with a diabetic pregnancy were enrolled in this study. Exclusion criterion 
was refusal to consent. All diabetic births (inborn) and outborn IDMs <28 days of life were 
enrolled. Exclusion criterion was parental refusal to consent. 
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Once a diabetic mother and her newborn infant were identified in the labour room, 
post-natal wards or neonatal wards of HUSM, the principal investigator and trained research 
assistants will collect data using a standardized data collection form.  
 
2.3 Case Definitions 
 GDM is defined as any degree of glucose intolerance which is first recognised during 
pregnancy, whether or not the condition persists after pregnancy.14 Screening is usually done 
at any government maternal and child health clinic. Initial screening of high-risk women for 
GDM at booking (selective screening) can be performed using: a) 75-g modified oral glucose 
tolerance test (mOGTT), with 0-minute (considered as fasting plasma glucose) and 120-
minute plasma glucose measurements, or b) fasting plasma glucose (FPG). FPG >5.1 mmol/L 
or 120-minute plasma glucose >7.8 mmol/L is considered diagnostic. 
 PGDM is defined as type 1 or type 2 DM that is diagnosed before the pregnancy. 
Screening is usually done at any government community clinic. Tests that can be performed 
are HbA1c, oral glucose tolerance test (OGTT – gold standard), FPG or random blood 
glucose (RBS). HbA1c >6.3%, FPG >7.0 mmol/L, RBS >11.1 mmol/L or 120-minute plasma 
glucose >11.1 mmol/L is considered diagnostic.14 Differentiating type 1 and type 2 DM is 
done after DM is confirmed and is based on C-peptide and autoantibodies levels. For this 
study, both are grouped under PGDM. 
A neonatal morbidity refers to any neonatal condition, from literature, that is related 
to a diabetic pregnancy. Those conditions are macrosomia, neonatal jaundice (NNJ), 
respiratory distress, hypoglycaemia, hypocalcaemia, polycythaemia, feeding intolerance, 
thrombocytopaenia, hypomagnesaemia, meconium aspiration syndrome (MAS), birth trauma,  
birth asphyxia, and hypertrophic obstructive cardiomyopathy (HOCM).  
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A severe neonatal morbidity is a condition that requires intensive neonatal care i.e. 
respiratory distress and MAS requiring invasive mechanical ventilation, severe NNJ requiring 
exchange transfusion, polycythaemia requiring partial exchange transfusion (PET), 
thrombocytopaenia requiring platelet transfusion, any birth trauma, hypertrophic obstructive 
cardiomyopathy (HOCM) and hypoxic ischaemic encephalopathy (HIE) at least grade II.  
A major birth defect is any structural defect present at birth that affect the baby 
functionally, socially and cosmetically.19 This study focuses on birth defects detected during 
the neonatal period. A minor birth defect is a variation of normal birth characteristics – any 
structural defect present at birth that does not impact a baby’s health or function or minimally 
impact its appearance.19 A birth defect is not included as a neonatal morbidity. 
 
2.4 Instruments 
There are three data collection forms – Appendix 1 (antenatal history), Appendix 2 
(physical examination), Appendix 3 (neonatal morbidities) and Appendix 4 (post-discharge 
progress).  
All enrolled mothers were clerked for their antenatal history particularly their diabetes 
history and management (Appendix 1).  
All babies were screened for major and minor birth defects based on the World Health 
Organization Birth Defects Surveillance Manual (Appendix 2)19 with some modifications. 
The manual is a guideline for assessment of external features to help establish birth defect 
screening programmes in underdeveloped and developing countries. We followed the manual 
for standardization purposes and only investigated further when clinically suggestive for 
internal birth defects.  
If a baby was admitted, the neonatal morbidities were documented upon discharge 
from the neonatal ward (Appendix 3).  
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All babies with major and minor birth defects were followed up at 2-6 weeks post-
discharge to review their growth and general wellbeing (Appendix 4). 
 
2.5 Statistical Analysis 
Collected data was analysed using IBM Statistical Package for Social Sciences 
(SPSS) for Windows version 22. Numerical data was presented as mean and standard 
deviation (SD) when normally distributed while categorical data was presented as frequency 
and percentage.  
Independent t-test was used to determine the association between HbA1c level with 
neonatal morbidities and with birth defects. 
Binary logistic regression (BLR) was used to determine the relationship of various 
sociodemographic and biological factors that contribute to neonatal morbidity and birth 
defects. BLR was done for the presence of neonatal morbidity, and then repeated for the 
presence of birth defects. The independent variables were maternal age, race, maternal 
education level, total household income level, booking trimester, booking BMI, pregnancy 
planning, type of DM and HbA1c level.  
Following univariate BLR for each independent variable, variables with p <0.25 were 
analysed in multivariate BLR. Then, statistically insignificant variables (p >0.05) were 
removed from the model and multivariate analysis was done with the remaining significant 
variables. The steps were repeated until the final model was formed i.e. all remaining 
independent variables were significant (p <0.05). 
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3.0 RESULTS 
3.1 Basic Demography  
Throughout the study period of 4 months, there were 2854 live births and 11 still 
births. 306 mothers with live births and 1 mother with still birth were diabetic. The incidence 
of diabetic pregnancy was 10.6% of all live births. We did not enrol miscarried diabetic 
pregnancies.  
307 diabetic mothers were approached for enrolment – 300 accepted and 7 refused. 8 
forms were incomplete during data entry and thus dropped out, leaving 292 samples for 
analysis as summarized in Chart 1. Their mean birth weight was 3.12kg (1.16 to 5.20kg; SD 
0.60). The demographical data are shown in Table 1.  
There was poor periconceptional awareness among these mothers as a) 70% of these 
pregnancies were unplanned although wanted, b) 7.5% booked their pregnancy during second 
and third trimesters, and c) 12% of diabetic mothers do not know their pre-pregnancy BMI or 
height and weight. 
 
3.2 Maternal HbA1c Levels 
221 diabetic mothers (76% of all diabetic live births) had documented HbA1c level at 
least once and 71 mothers did not have HbA1c measurement (24%) as shown in Table 2.  
Out of 27 mothers with PGDM, only 9 mothers had pregestational HbA1c taken (33% 
of all PGDM mothers). 44 diabetic mothers had first trimester HbA1c taken; 92 second 
trimester HbA1c taken; and 76 had third trimester HbA1c taken. 
The mean HbA1c for pregestational period was 9.0% (5.3-12.5%; SD 2.70), first 
trimester was 6.7% (4.2-11.1%; SD 1.90), second trimester was 5.6% (4.0-11.0%; SD 1.11) 
and third trimester was 5.9% (4.3-10.0%; SD 1.20). 
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3.3 Neonatal Morbidities 
101 newborn IDMs (35% of all diabetic live births) were admitted. The mean days of 
admission was 9.01 days (from 1 to 65 days, SD 10.43). 94 newborn IDMs (32% of all 
diabetic live births) had at least one neonatal morbidity (as shown in Table 2). 26 infants (9% 
of all diabetic live births) had at least one severe neonatal morbidity. 7 admitted IDMs did not 
have any neonatal morbidity; they had different indications e.g. presumed sepsis.  
Briefly, there were more cases of neonatal jaundice followed by respiratory distress, 
hypoglycaemia, and macrosomia as shown in Chart 2 and Table 3.  
 
3.3 Birth Defects 
10 infants had major defects (3.4% of all IDMs) and 27 infants had minor birth 
defects (9.2%) as shown in Chart 3, Chart 4 and Table 4. The only stillbirth was delivered 
with a weight of 4.95kg at 36 weeks. It was a normally formed fresh stillbirth. It was 
macrosomic but no obvious birth defects were observed. 
 Our study observed that congenital heart disease is the most prevalent major birth 
defect (1.8% of IDMs); followed by various syndromes (1.5%); neural tube defect (0.6%); 
cleft palate (0.3%); abdominal defect (0.3%); and limb defect (0.3%). 
 We found 20 types of minor birth defects. 9.2% of IDMs had minor birth defects with 
ear defects being the most prevalent (7.6%); followed by upper limb defects (1.9%); neck 
defects (1.2%); and lower limb and trunk defects (both 0.6%). Some babies have more than 
one minor birth defect – these are usually not pursued further unless clinically suspicious of a 
syndrome or association.  
 We did not look at birth defects in healthy controls to compare. 
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3.4 Statistical Analysis 
3.4.1 Factors Affecting Neonatal Morbidity 
An independent t test (equal variances not assumed) was carried out for the presence 
of neonatal morbidity and third trimester HbA1c as shown in Table 6. Infants with neonatal 
morbidity had statistically higher mean third trimester HbA1c level (6.448 ± 1.36%) 
compared to infants without neonatal morbidity (5.525 ± 0.97%), t (41) = -3.113, p = 0.003. 
 BLR was performed to assess the relationship of the risk factors with neonatal 
morbidity as shown in Table 7. Third trimester HbA1c showed significant association with 
neonatal morbidity (x2 (step) = 22.877, p <0.001, Nagelkerke R2 = 0.388). Every 1% increase 
in HbA1c will increase the odds of having neonatal morbidity by 2.2 times. A third trimester 
HbA1c of less than 6% is 0.17 times likely to have neonatal morbidity, whereas a third 
trimester HbA1c of less than 6.5% is 1.02 times likely to have neonatal morbidity. In other 
words, aiming of HbA1c level < 6.5% will not affect the odds of having neonatal morbidities. 
  
3.4.2 Factors Affecting Birth Defects 
There was no significance of the mean pregestational HbA1c difference between 
infants with birth defects and infants without birth defects. There was statistical significance 
between major birth defects and late booking as shown in Table 8. A late pregnancy booking 
for a diabetic pregnancy is 1.6 times likely to result in a birth defect. The other biological and 
sociodemographic factors analysed did not show significant association with the presence of 
birth defects. 
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4.0 DISCUSSION 
 This cross-sectional study was conducted in Kelantan, one of the underdeveloped 
states in Malaysia. 99% mothers in this study were Malay reflecting the Kelantan state 
demography – hence, a population bias. 
 The incidence of diabetic pregnancies was similar to background local data (8.5-
10.5% of all pregnancies).3 There was a rise in T2DM pregnancies from 8.5%3 to 10.5% in 
five years, indicating more women with chronic illnesses were well enough to get pregnant – 
a feature that is seen more often in Westernized developing countries.9 
 
4.1 Late Diagnosis of GDM due to Selective Antenatal Screening  
 In Malaysia, pregnant women are screened selectively for GDM due to limited 
resources. This practice had been shown to be ineffective to improve pregnancy 
outcomes.14,20 This leads to a late diagnosis of GDM as we unintentionally wait for 
complications to occur first before screening for GDM. A long turnaround time for HbA1c 
result and a late diagnosis of GDM are possible reasons to explain 24% of GDM mothers did 
not have HbA1c level available upon delivery. 
 
4.2 Lack of Awareness for Good Periconceptional and Antenatal Practices 
 Pre-conceptional counselling and good glucose control (HbA1c <6.5, weight 
reduction in overweight women, folate supplementation) are stressed upon nationally.14 
Despite this, there was still poor periconceptional awareness among these mothers as more 
than two thirds of these pregnancies were unplanned, leading to late booking and 
subsequently late diagnosis of GDM. Lack of knowledge regarding their weight and height 
also reflect poorly on their awareness regarding nutritional control before and during 
pregnancy.  
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 68% of established diabetic women did not have HbA1c recorded prior to conception. 
And when available, the HbA1c level ranged from 5.3 to 12.5, showing that women with 
established DM were a) still at risk for foetal teratogenicity despite having long-term 
pregestational medical follow-up, and b) exhibiting a lack of awareness for pregnancy 
planning. 
 Analyses of their knowledge, attitude and practise towards the periconceptional 
period should be undertaken to improve pregnancy outcomes. 
 
4.3 Neonatal Morbidities 
 In our study, 35% of all diabetic live births were admitted as compared to 0.2% in 
1989.1 Such an increase is most likely due to lower threshold for neonatal admission given 
the growing evidence of neonatal morbidities and birth defects that occur in IDMs. 
 14% of IDMs in our study were macrosomic, as compared to 37% in the 1989 
Hospital Kuala Lumpur (HKL) study. Another HKL study in 2006 showed that infants of 
GDM mothers were 9.8 times more likely to be macrosomic.10 A macrosomic IDM is 2-2.5 
times at risk of becoming an obese adult.9 
 On the other end, 38% had low birth weight as compared to 7.4% in 1989. Low birth 
weight in IDMs – which most likely occurs due to poor placental vascular formation and 
chronic hypoxia in utero – leads to polycythaemia, feeding difficulties, hypothermia and in 
the long-term, leads to an increased risk of DM in the young adult.9 Attention that is given to 
macrosomic infants should be fairly given to IDMs with low birth weight. 
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 NNJ requiring hospital admission remained the most common morbidity of IDMs – 
30.8% compared to 50% in 1989. This was still higher than normal population (10%)21 due to 
increased red cell mass, increased haemolysis and increased bruises during delivery in 
IDMs.22 Despite this, only 1% of IDM required exchange transfusion – similar to normal 
population. 
 Hypoglycaemia cases remained unchanged at 21.5%. Despite a change in cut-off level 
from less than 2.1mmol/l1 to our current definition of less than 3.0mmol/l, these percentages 
still fall within expected values of 10-25%.23  
 There was a similar incidence of respiratory distress – 9.3% in the 1989 HKL study 
and 11.2% in ours. 5.6% had meconium aspiration syndrome in both studies. These findings 
were similar to non-IDMs morbidities.23 The significant factors determining incidence of 
respiratory distress were prematurity and elective CS (not preceded by labour).23 
 Similar to other studies, birth trauma and birth asphyxia remained low (2.8% and 
4.1% respectively in our study) due to increased rates of Caesarean sections (CS) in diabetic 
mothers.5,10   
 There was an increase in incidence of symptomatic HOCM from 1.9% in HKL and 
3.7% in HUSM. It was low considering routine echocardiography would reveal 30% of IDM 
having various degrees of left ventricular outflow tract obstruction and 12% would be 
symptomatic.22  
 There was no data collected previously on metabolic effects of a diabetic pregnancy 
on a neonate. The metabolic effects include polycythaemia, thrombocytopaenia, 
hypocalcaemia and hypomagnesemia. This is the first study documenting additional effects of 
diabetic pregnancies in Malaysia whereby 10.6% had polycythaemia, 17% had 
thrombocytopaenia, 23% had hypocalcaemia and 10.6% had hypomagnesemia.  
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 Evidence had shown diabetic effects on blood components and electrolytes, however 
there were no expected values.24 A significant association between hypomagnesaemia and 
hypocalcaemia is postulated to be due to hypomagnesemia-induced functional 
hypoparathyroidism.24 
 While there was good evidence showing high HbA1c as a predictor of neonatal 
morbidity mainly macrosomia and hypoglycaemia,7 evidence of the efficacy of GDM 
treatment on the foetal outcome had been conflicting.10  
 Our study showed despite overall good antenatal glucose control as reflected by the 
mean third trimester HbA1c being within the target range, neonatal outcomes are still not 
satisfactory. There is still room for improvement particularly maternal awareness and tighter 
glucose control (despite some worry that a strict glucose control may lead to small-for-age 
infants).23  
 
 4.4 Birth Defects 
 Worldwide, 5-14% of IDMs have major birth defects13,23 while 3-4% occur in the 
normal population. In Malaysia, 7.4% of IDMs had major birth defects in the 1989 study and 
3.0% in our 2017 study – within the observed range. Our study follows a similar pattern of 
observation of birth defects in IDMs. 
 This study found there was statistical significance between major birth defects and 
late booking. A late booking would explain the risk of undiagnosed pregestational and early 
trimester hyperglycaemia, leading to teratogenicity and incidence of birth defects. On the 
other hand, a statistical significance to pregestational HbA1c was not found despite 
established science. A larger sample size and inclusion of the first trimester HbA1c in the 
analysis would improve the analysis. 
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 Current literature states that 1.2-42.9% IDMs have minor birth defects.25 Some studies 
were more sensitive due to differences in case definitions.25 A 9-year study on IDMs and 
their non-diabetic controls in 1992 noted that the prevalence of minor birth defects was 
similar in both groups (19-20%).23,25 There are more minor ear defects in our study but there 
was no observable patterns for minor birth defects in IDMs in past studies.6,25 Evidence is 
inadequate to conclude whether the existence of such pattern is significant or not in 
understanding further the pathophysiology of minor birth defects.  
 For future studies, we suggest adhering to a standardized system of detection in order 
to improve the data. We based our physical examination according to the WHO birth defect 
manual albeit with some modifications. The manual is an assessment of external features 
alone as it aims to help establish birth defect screening programmes. We followed it for 
standardization purposes and only investigated further when clinically suggestive for e.g. 
congenital heart defect or intracranial abnormality.  
 Some of the birth defects were difficult to assess e.g. assessment of the uvula non-
invasively was time-consuming as it required the baby to cry or yawn in order to be 
visualized. Difficulty in such assessments could lead to underdiagnosis of these minor birth 
defects. To improve the diagnosis, assessment by a paediatrician or geneticist should be 
carried out. In our study, this was not done due to limited resources. 
 
4.5 Postnatal follow-up 
 We followed up on 37 infants with minor and major birth defects at 2-6 weeks of life 
after discharge from the hospital. Most of them adapted well to extra-hospital life and thrived. 
7 babies were readmitted (27.2%) for various issues. 1 baby with Down syndrome died at 3 
months old for severe pneumonia. 
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5.0 CONCLUSION 
The current antenatal practice is suboptimal despite good maternal antenatal glucose 
control as the incidence of neonatal morbidities of infants of diabetic mothers is high. 
Universal screening for GDM, emphasis on maternal education, better access to assessment 
tools and stricter glycaemic control (HbA1c <6.3) will lead to a better pregnancy outcome. 
Further studies documenting similar incidences of neonatal morbidities will make a stronger 
case for a national review of the national clinical practice guidelines. 
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APPENDIX 
 
 
Chart 1. Flowchart of the study 
 
 
 
 
 
 
 
Mothers and neonates enrolled from labour 
room/OT/neonatal wards/postnatal wards
(N=306)
Data collected
(N=300)
Final number of subjects
(N=292)
Descriptive analysis
(N=292)
Mothers with pregestational
HbA1c
(N=9)
Analysis of HbA1c associated 
with birth defects
- independent t-test
Mothers with third trimester 
HbA1c
(N=76)
Analysis of HbA1c associated 
with neonatal morbidities
- independent t-test
Babies with at least one 
neonatal morbidity
(N=94)
Analysis for factors 
associated with neonatal 
morbidities
- Binary logistic regression
Babies with at least one major 
birth defect
(N=10)
Analysis for factors 
associated with birth defects
- Binary logistic regression
Dropped out
- incomplete forms (N=8)
Excluded
- Refused to participate (N=6) 
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Chart 2. Neonatal morbidities (n = 94) 
 
* Some infants may have more than one neonatal morbidity. 
 
Chart 3. Major birth defects (n = 10)                    Chart 4. Minor birth defects (n = 27)                          
 
 
 
* Some infants may have more than one birth defect. 
 
79
27
23
22
20
18
16
10
7 5
4 41
NNJ Respiratory distress Hypoglycaemia
Hypocalcaemia Polycythaemia Feeding intolerance
Thrombocytopaenia Hypomagnesaemia MAS
Birth trauma Birth asphyxia HOCM
Death
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6
5
4
2
2 1
Ears defect Upper limb defect
Eyes defect Neck defect
Lower limb defect Trunk defect
Oral cavity defect
6
5
2
1
1
1
Congenital heart disease
Syndromic
Neural tube defect
Cleft palate
CTEV
Perianal lipoma
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Table 1. Demographic data for diabetic mothers (n = 292) 
Characteristics Frequency Percentage (%) 
Age (years) 
     20-25 
     26-30 
     31-35 
     36-40 
     >40 
 
35 
91 
92 
56 
18 
 
12.1% 
31.3% 
31.3% 
19.1% 
6.2% 
Race 
     Malay 
     Chinese 
     Indian 
     Others 
 
288 
3 
0 
1 
 
98.6% 
1.0% 
0.0% 
0.3% 
Education 
     Primary 
     Secondary 
     Tertiary 
 
6 
137 
149 
 
2.1% 
46.9% 
51.0% 
Household income (RM) 
     < RM1,000 
     RM1,000-5,000 
     RM5,000-10,000 
     > RM10,000 
 
29 
195 
66 
2 
 
10.0% 
66.8% 
22.6% 
0.6% 
Planned pregnancy 
     Yes 
     No 
 
87 
205 
 
29.8% 
70.2% 
Previous history of GDM 
     Yes 
     No  
 
83 
209 
 
28.4% 
71.6% 
Booking trimester 
     First 
     Second 
     Third 
 
270 
17 
5 
 
92.5% 
5.8% 
1.7% 
Booking BMI 
     < 20 
     20-25 
     25-30 
     > 30 
     Missing 
 
15 
70 
94 
81 
32 
 
1.6% 
24.0% 
34.5% 
27.7% 
12.2% 
 
 
 
  
